by admin | Mar 24, 2022 | Insights
An overview of recent psychedelic decriminalization trends out of Georgia, Missouri, Washington State, Oklahoma, Oregon and Utah. #psychedelicscience #psilocybin #psychedelicresearch #psychedelicmedicine #decriminalization #psychedelics #USA...
by admin | Mar 24, 2022 | Insights
Few things open doors like access to funds. It’s the fuel that lights the way, allowing scientists and researchers and entrepreneurs to build an entirely new industry.” An interesting overview on how capital is fuelling innovation, development and confidence in...
by admin | Mar 24, 2022 | Insights
People who have gone through traumatic events should be able to have tools at their disposal that can help them live better lives.” A new $1 million grant will fund researchers at The Johns Hopkins University, Yale University, and New York University to develop...
by admin | Mar 14, 2022 | Insights
In follow up to yesterday’s post in The Guardian, Professor Jo Neill outlines the evidence-based case for the rescheduling of psilocybin and other drugs, including the benefits they can bring to health and the UK economy in this blog from Drug Science....
by admin | Mar 14, 2022 | Insights
The United Kingdom are urging Cabinet ministers to reclassify psilocybin so that researchers can explore its potential as a medicine. The same demand is being made by people suffering from cluster headaches, amid evidence that psilocybin can help reduce both the...
Recent Comments